The White House on Thursday announced that it has finalized negotiations with the manufacturers of the 10 drugs selected for the first round of drug price negotiation under the Biden Administration’s Inflation Reduction Act of 2022 (IRA), which the Administration said will save $1.5 billion in out-of-pocket costs for prescription drugs for people on Medicare and will save Medicare $6 billion “in the first year alone.”
Recent Posts
- Chamber Says White House Announcement on Medicare Drug Prices Threatens Patient Access
- CAFC Says District Court Erred in Rejecting Unlawful-Use Defense in Trademark Infringement Context
- CAFC Says ‘First-Filed, First-Issued, Later Expiring Claim’ is Not Invalid for ODP
- Inside the Beltway: The Politics of Innovation and Patent Policy | IPWatchdog Unleashed
- CAFC Says Vidal Recusal as Petitioner’s Counsel Avoided Due Process Violation in IPR